» Authors » S E Svehag

S E Svehag

Explore the profile of S E Svehag including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 204
Citations 1106
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Horvath A, Andersen I, Junker K, Holm Nielsen E, Gizurarson S, Andersen O, et al.
Antiviral Res . 2001 Sep; 52(1):43-53. PMID: 11530187
Serum amyloid P component (SAP) binds in vitro Ca(2+)-dependently to several ligands including oligosaccharides with terminal mannose and galactose. We have earlier reported that SAP binds to human influenza A...
2.
Zimmermann-Nielsen E, Svehag S, Thorlacius-Ussing O, Baatrup G
J Immunol Methods . 2001 Feb; 249(1-2):43-51. PMID: 11226462
An ELISA that measures plasma derived complement (C) split-products C3b/iC3b deposited on solid-phase immune complexes during C activation is described. Plates are coated with BSA, anti-BSA and plasma is added....
3.
Sorensen I, Holm Nielsen E, Schroder L, Voss A, Horvath L, Svehag S
J Clin Immunol . 2001 Feb; 20(6):408-15. PMID: 11202230
Serum amyloid P component (SAP) binds in vitro to DNA; based on findings in SAP-deficient mice it was proposed that SAP's role is to handle chromatin and DNA, thereby preventing...
4.
Holm Nielsen E, Nybo M, Junker K, Toftedal Hansen P, Rasmussen I, Svehag S
Scand J Immunol . 2000 Aug; 52(2):110-2. PMID: 10931376
Ultrastructural studies of the localization of serum amyloid P component (SAP) in amyloid fibrils have given divergent results. We here report for the first time that electron microscopy of SAP...
5.
Nybo M, Nielsen E, Svehag S
Amyloid . 1999 Dec; 6(4):265-72. PMID: 10611947
Complement activation (CA) has been reported to play a role in the pathogenesis of Alzheimer's disease (AD). To investigate whether CA may contribute to amyloidogenesis in general, the CA potential...
6.
Nielsen E, Nybo M, Svehag S
Methods Enzymol . 1999 Oct; 309:491-6. PMID: 10507043
No abstract available.
7.
Nybo M, Svehag S, Holm Nielsen E
Scand J Immunol . 1999 Apr; 49(3):219-23. PMID: 10102637
Many attempts have been made to define early stages and intermediates in amyloid fibrillogenesis that may be susceptible to inhibition. We have developed an in vitro system, based on the...
8.
Nybo M, Hackler R, Kold B, Nielsen E, Steinmetz A, Svehag S
Scand J Immunol . 1998 Oct; 48(4):350-6. PMID: 9790304
Isoelectric focusing (IEF) and immunofixation of murine serum amyloid P component (SAP), purified and in serum, showed a distinct and strain-dependent isoform pattern with up to seven bands (pI 5.1-5.7)....
9.
Junker A, Baatrup G, Svehag S, Wang P, Holmstrom E, Sturfelt G, et al.
Scand J Immunol . 1998 Jun; 47(5):481-6. PMID: 9627133
The capacity of serum to support deposition of C3, properdin and factor B was studied by enzyme-linked immunosorbent assay using solid-phase immune complexes (IC) for activation of complement. Deposition of...
10.
Nybo M, Olsen H, Jeune B, Andersen-Ranberg K, Holm Nielsen E, Svehag S
Dement Geriatr Cogn Disord . 1998 Jun; 9(3):126-9. PMID: 9621998
Serum amyloid P component (SAP) binds to all amyloid fibrils including those in the plaques and tangles of Alzheimer patients. To investigate whether the plasma SAP concentration correlated to cognitive...